|
Volumn 72, Issue 8, 2011, Pages 1130-1138
|
Evaluation of a commercially available modifed-live streptococcus equi subsp equi vaccine in ponies
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ERYTHROMYCIN;
IMMUNOGLOBULIN G;
LIVE VACCINE;
TETRACYCLINE;
ABSCESS;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ANTIBODY DETECTION;
ANTIBODY TITER;
ARTICLE;
BACTERIUM CULTURE;
CLINICAL EFFECTIVENESS;
CLINICAL FEATURE;
CONTROLLED STUDY;
DRUG SAFETY;
DRUG SCREENING;
FEMALE;
GENE;
HORSE;
LYMPHADENOPATHY;
MALE;
NONHUMAN;
PHYSICAL EXAMINATION;
RRS GENE;
SEM GENE;
STREPTOCOCCUS EQUI;
STREPTOCOCCUS EQUI ZOOEPIDEMICUS;
ANIMALS;
BACTERIAL PROTEINS;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
FEMALE;
HORSE DISEASES;
HORSES;
ILLINOIS;
LYMPH NODES;
MALE;
STREPTOCOCCAL INFECTIONS;
STREPTOCOCCAL VACCINES;
STREPTOCOCCUS EQUI;
VACCINATION;
VACCINES, ATTENUATED;
ANIMALIA;
STREPTOCOCCUS EQUI;
|
EID: 80052759799
PISSN: 00029645
EISSN: None
Source Type: Journal
DOI: 10.2460/ajvr.72.8.1130 Document Type: Article |
Times cited : (24)
|
References (11)
|